help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 4, 2005
Endocrinology, doi:10.1210/en.2005-0514
A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/11/4755    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, K.
Right arrow Articles by Frank, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, K.
Right arrow Articles by Frank, S. J.

Submitted on April 29, 2005
Accepted on July 29, 2005

JAK2 Enhances the Stability of the Mature GH Receptor

Kai He, Kimberly Loesch, Jon W. Cowan, Xin Li, Luqin Deng, Xiangdong Wang, Jing Jiang, and Stuart J. Frank*

Endocrinology Section, Medical Service, Veterans Affairs Medical Center, Birmingham, AL; Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL; Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

* To whom correspondence should be addressed. E-mail: sjfrank{at}uab.edu.

The abundance of surface GHR is an important determinant of cellular GH sensitivity and is regulated at both transcriptional and post-transcriptional levels. In previous studies of GHR-expressing JAK2-deficient human fibrosarcoma cells ({gamma}2A-GHR), we demonstrated that stable transfection with JAK2 resulted in increased steady-state levels of mature GHR (endoH-resistant; Mr 115-140 kD) relative to precursor GHR (endoH-sensitive; Mr 100 kD). We now examine further the effects of JAK2 on GHR trafficking by comparing {gamma}2A-GHR to {gamma}2A-GHR cells stably reconstituted with JAK2 (C14 cells). In the presence of JAK2, GHR surface expression was increased, as assessed by surface biotinylation, 125I-hGH cell surface binding, and immunofluorescence microscopy assays. While the absence of JAK2 precluded GH-stimulated signaling, GH-induced GHR disulfide linkage (a proxy for the GH-induced conformational changes in the GHR dimer) proceeded independent of JAK2 expression, indicating that the earliest steps in GH-induced GHR triggering are not prevented by the absence of JAK2. RNA interference-mediated knockdown of JAK2 in C14 cells resulted in a decreased mature:precursor ratio, supporting a primary role for JAK2 either in enhancing GHR biogenesis or dampening mature GHR degradation. To address these potential mechanisms, metabolic pulse-chase labeling experiments and experiments in which the fate of previously synthesized GHR was followed by anti-GHR immunoblotting after cycloheximide treatment ("cycloheximide chase" experiments) were performed. These indicated that the presence of JAK2 conferred modest enhancement (1.3-1.5-fold) in GHR maturation, but substantially prolonged the t1/2 of the mature GHR, suggesting a predominant effect on mature GHR stability. Cycloheximide chase experiments with metalloprotease, proteasome, and lysosome inhibitors indicated that the enhanced stability of mature GHR conferred by JAK2 is not related to effects on constitutive receptor metalloproteolysis, but rather is due to reduced constitutive endosomal/lysosomal degradation of the mature GHR. These results are discussed in the context of emerging information on how JAK-family members modulate surface expression of other cytokine receptors.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. G. S. Kumar, B. Varghese, A. Banerjee, D. P. Baker, S. N. Constantinescu, S. Pellegrini, and S. Y. Fuchs
Basal Ubiquitin-independent Internalization of Interferon {alpha} Receptor Is Prevented by Tyk2-mediated Masking of a Linear Endocytic Motif
J. Biol. Chem., July 4, 2008; 283(27): 18566 - 18572.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Asa, R. DiGiovanni, J. Jiang, M. L. Ward, K. Loesch, S. Yamada, T. Sano, K. Yoshimoto, S. J. Frank, and S. Ezzat
A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors
Cancer Res., August 1, 2007; 67(15): 7505 - 7511.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Nilsson, G. Bjursell, and M. Kannius-Janson
Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells
Mol. Cell. Biol., August 1, 2006; 26(15): 5663 - 5674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Radtke, A. Jorissen, H. S.-V. de Leur, P. C. Heinrich, and I. Behrmann
Three Dileucine-like Motifs within the Interbox1/2 Region of the Human Oncostatin M Receptor Prevent Efficient Surface Expression in the Absence of an Associated Janus Kinase
J. Biol. Chem., February 17, 2006; 281(7): 4024 - 4034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society